Treatments & Interventions
Procarbazine hydrochloride
substance
Thalidomide
substance
Doxorubicin hydrochloride
substance
Interferon alfacon-1
substance
Interferon gamma-1b
substance
Interferon alfa-2a
substance
Interferon alfa-2b
substance
Aldesleukin
substance
Carmustine
substance
Melphalan
substance
Cisplatin
substance
Cyclophosphamide
substance
Procarbazine
substance
Peginterferon alfa-2b
substance
Zoledronic acid
substance
Bortezomib
substance
Lenalidomide
substance
Peginterferon alfa-2a
substance
Melphalan hydrochloride
substance
Panobinostat
substance
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Related Conditions
Quick Facts
- SNOMED CT
- 109989006
- UMLS CUI
- C0026764
- Fully Specified Name
- Multiple myeloma (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 30
- Known Treatments
- 20
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.